Stubbs J, Horwitz A, Moses V
J Bacteriol. 1973 Oct;116(1):131-40. doi: 10.1128/jb.116.1.131-140.1973.
Merodiploid derivatives bearing an F-linked lac operon (i(+), o(+), z(+), y(+), a(+)) from Escherichia coli were prepared from a Proteus mirabilis strain unable to utilize lactose and from a lac deletion strain of E. coli. A suitable growth medium was found in which the episomal element in the P. mirabilis derivative was sufficiently stable to allow induction of the episome-borne lac operon and thus to permit a comparison of the activities and properties of E. coli lac products in the intracellular environments of P. mirabilis and E. coli. In both derivatives the episomal lac operon was shown to be repressed in the absence of inducer. Kinetics of induction with gratuitous inducer (isopropyl-1-thio-beta-d-galactoside) were similar for both beta-galactosidase activity (beta-d-galactoside galactohydrolase, EC 3.4.1.23) and beta-galactoside transport activity in both derivatives, although the ratio of galactoside transport to beta-galactosidase activity was approximately 1.6-fold higher in the E. coli derivative. Comparison of beta-galactosidase and M-protein (lac y gene product)-specific activities indicated coordinate expression of the induced lac operon in both derivatives. Quantitatively, the maximal beta-galactosidase specific activity was two or three times higher for the E. coli derivative. A significant sodium azide inhibition (65% inhibition by 10 mM sodium azide) of lactose permease-mediated transport of o-nitrophenyl-beta-galactoside from an outside region of high concentration to an inside region of very low concentration ("downhill transport") was observed for the P. mirabilis derivative. Identical conditions for the E. coli derivative yielded only about 15% inhibition. Active transport of thiomethyl-beta-galactoside was similar for both derivatives, the major difference being that active transport was more sensitive to azide poisoning in the P. mirabilis derivative. Preliminary examination of the thiomethyl-beta-galactoside derivatives following active transport did not demonstrate the accumulation of a phosphorylated product in either strain but did reveal an unidentified derivative present in the P. mirabilis merodiploid extract which was not detectable in the E. coli merodiploid.
从一株不能利用乳糖的奇异变形杆菌菌株和一株大肠杆菌乳糖缺失菌株中制备了带有来自大肠杆菌的 F 连锁乳糖操纵子(i(+)、o(+)、z(+)、y(+)、a(+))的部分二倍体衍生物。发现了一种合适的生长培养基,其中奇异变形杆菌衍生物中的附加体元件足够稳定,能够诱导附加体携带的乳糖操纵子,从而可以比较大肠杆菌乳糖产物在奇异变形杆菌和大肠杆菌细胞内环境中的活性和特性。在这两种衍生物中,附加体乳糖操纵子在没有诱导剂的情况下都被证明是受抑制的。对于两种衍生物中的β-半乳糖苷酶活性(β-d-半乳糖苷半乳糖水解酶,EC 3.4.1.23)和β-半乳糖苷转运活性,用 gratuitous 诱导剂(异丙基-1-硫代-β-d-半乳糖苷)诱导的动力学相似,尽管在大肠杆菌衍生物中半乳糖苷转运与β-半乳糖苷酶活性的比值大约高 1.6 倍。β-半乳糖苷酶和 M 蛋白(乳糖 y 基因产物)比活性的比较表明,在两种衍生物中诱导的乳糖操纵子是协同表达的。从数量上看,大肠杆菌衍生物的最大β-半乳糖苷酶比活性高两到三倍。对于奇异变形杆菌衍生物,观察到乳糖通透酶介导的邻硝基苯基-β-半乳糖苷从高浓度外部区域到极低浓度内部区域的“下坡运输”受到显著的叠氮化钠抑制(10 mM 叠氮化钠抑制 65%)。大肠杆菌衍生物在相同条件下仅产生约 15%的抑制。两种衍生物中硫代甲基-β-半乳糖苷的主动运输相似,主要区别在于奇异变形杆菌衍生物中的主动运输对叠氮化钠中毒更敏感。对主动运输后的硫代甲基-β-半乳糖苷衍生物进行的初步检查未在任何一种菌株中证明有磷酸化产物的积累,但确实揭示了奇异变形杆菌部分二倍体提取物中存在一种在大肠杆菌部分二倍体中无法检测到的未鉴定衍生物。